Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NinePoint Medical developed and commercialized the NvisionVLE Imaging System—a next-generation OCT-based endoscopic imaging platform that enables real-time volumetric visualization up to several millimeters beneath mucosal surfaces. The system received multiple FDA clearances for GI tract indications including Barrett’s esophagus surveillance and pancreatico-biliary evaluation. Clinical trials demonstrated improved detection of dysplasia in Barrett’s esophagus using this technology. The company also launched an AI-powered image segmentation tool (“IRIS”) to assist clinicians in interpreting images.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NinePoint Medical.